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Executive Summary 
The 2011 MDPH Massachusetts Arbovirus Surveillance and Response plan provides surveillance and 
phased response guidance for both West Nile virus (WNV) and eastern equine encephalitis virus (EEE).  
In the past six years there have been sixteen cases of WNV infection reported in Massachusetts and 
fourteen human cases of EEE resulting in seven deaths. This plan reflects a comprehensive review of 
surveillance activities, mosquito control efforts, public information and risk communication related to 
arbovirus control in Massachusetts.  
 
The purpose of the plan is to provide guidance on operational aspects of surveillance and response by 
state and local agencies responsible for the prevention of mosquito-borne disease in the 2011 season. 
The Department of Public Health will continue to seek advice from its partners and collaborators and 
modify the plan, as appropriate. This document is open to continual review and evaluation. Information is 
provided to guide planning and actions to reduce the risk of human disease from EEE and WNV.   
 
Key objectives contained in this plan provide for:  
 
 Monitoring of trends in EEE and WNV activity in Massachusetts;  
 timely collection and dissemination of information on the distribution and intensity of WNV and EEE in 
the environment;  
 laboratory diagnosis of WNV and EEE cases in humans, horses and other animals;  
 effective communication, advice and support of activities that may reduce risk of infection;  
 phased response to provide measures to suppress the risk of infection. 
 
This document provides information about EEE and WNV disease and program goals, and specific 
guidelines for mosquito, equine and human surveillance.  Additionally, this document provides guidance 
for the dissemination of information, including routine information; media advisories of positive EEE and 
WNV findings in mosquitoes, as well as public health alerts related to positive EEE and WNV human 
cases.              
 
This plan describes MDPH’s public outreach efforts to provide helpful and accurate communication with 
Massachusetts’ residents about their risk from arboviral diseases and specific actions that individuals and 
communities can take to reduce this risk. 
 
 
I.   INTRODUCTION 
 
The Massachusetts Department of Public Health (MDPH), in collaboration with the State Reclamation 
Mosquito and Control Board (SRMCB) and regional mosquito control projects (MCP’s), conducts 
surveillance for mosquito-borne viruses that pose a risk to human health. The Massachusetts Arbovirus 
Surveillance Program (MASP): 
 
 tests mosquitoes, specimens from appropriate suspect animals and from humans for evidence of 
infection;  
 identifies areas of disease risk;  
 provides information to guide decision-making to reduce the risk of disease; and 
 informs the public of where and when there is an increased risk of infection.  
 
The MASP currently focuses on West Nile (WNV) and eastern equine encephalitis (EEE) viruses, which 
are found in the local environment and are capable of causing serious illness and death in humans, 
horses and other mammals. 
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The 2011 Massachusetts Surveillance and Response Plan for mosquito-borne diseases is based on a 
comprehensive plan initially developed for WNV in 2001 in collaboration with local health agencies, other 
state agencies, academic institutions, the Centers for Disease Control and Prevention (CDC), and 
interested groups and individuals. It incorporates components of the state’s EEE surveillance activities, 
which began in the 1950’s and have continued since that time. The MASP began monitoring for WNV 
following a 1999 outbreak of human WNV disease in the New York City area, the first known occurrence 
of this disease in North America. WNV was identified in birds and mosquitoes in Massachusetts during 
the summer of 2000 and has been found during each consecutive season.  
 
The updated 2011 plan is the result of analyses of surveillance data collected in Massachusetts and the 
United States. In addition, in order to manage the complexity of the human disease risk posed by these 
viruses, MDPH convened four workgroups that advised MDPH and promoted collaborative efforts by 
multiple agencies and interest groups. The purpose of the plan is to provide guidance on operational 
aspects of surveillance and response by the state and local agencies with responsibilities for the 
prevention of mosquito-borne disease.  MDPH will continue to seek advice from its partners and 
collaborators and modify the plan, as appropriate. This document is open to continual review and 
evaluation with changes made when there is opportunity for improvement.  
 
 
II. DISEASE HISTORY AND BACKGROUND 
 
The two principal mosquito-borne viruses (also known as arboviruses, for arthropod-borne viruses) 
recognized in Massachusetts and known to cause human and animal disease are eastern equine 
encephalitis virus with the first human cases identified in both the United States and Massachusetts in 
1938, and West Nile virus, with the first human case identified in the United States in 1999, and in 
Massachusetts in 2001.   
 
A. Eastern Equine Encephalitis Virus 
 
1. Background 
Eastern equine encephalitis is a serious disease, with 30-50% mortality and lifelong neurological disability 
among many survivors, which occurs sporadically in Massachusetts.  The first symptoms of EEE are 
fever (often 103º to106ºF), stiff neck, headache, and lack of energy.  These symptoms show up three to 
ten days after a bite from an infected mosquito. Inflammation and swelling of the brain, called 
encephalitis, is the most dangerous and frequent serious complication.  The disease gets worse quickly 
and some patients may go into a coma within a week. There is no treatment for EEE.  In Massachusetts, 
approximately half of the people identified with EEE have died from the infection.  People who survive this 
disease will often be permanently disabled. Few people recover completely.  
 
Historically, clusters of human cases have occurred in cycles lasting 2-3 years, with a hiatus of 10-20 
years between outbreaks. In the years between outbreaks, isolated cases may occur.  Outbreaks of 
human EEE disease in Massachusetts occurred in 1938-39 (35 cases, 25 deaths), 1955-56 (16 cases, 9 
deaths), 1972-74 (6 cases, 4 deaths), 1982-84 (10 cases, 3 deaths), 1990-92 (4 cases, 1 death), 2004-06 
(13 cases, 6 deaths). One human case of EEE occurred in 2010. 
 
 
Massachusetts Eastern Equine Encephalitis Experience 
Year(s) Human EEE Cases Human EEE Deaths 
1938-39 35 25 
1955-56 16 9 
1972-74 6 4 
1982-84 10 3 
1990-92 4 1 
2004-06 13 6 
             2010 1 0 
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The Massachusetts Department of Public Health, with CDC funding, initiated a field surveillance program 
in 1957; following a 1955-56 outbreak of EEE. The purpose of the program was to gather data to guide 
prevention and risk reduction of this disease. 
 
2. Risk Factors for Disease Transmission 
Eastern equine encephalitis virus is an enzootic alphavirus found in some passerine bird species living in 
fresh-water swamp habitats. The virus is transmitted among wild birds in these areas primarily by Culiseta 
melanura, and secondarily by Cs. morsitans in other regions, both are mosquito species that feed 
predominantly on birds. This mosquito-borne virus has a cycle of natural infection among bird populations 
with occasional ‘‘incidental” symptomatic infections in susceptible species including humans, horses, 
llamas, alpacas, emus and ostriches.  The prevalence of infection among birds is related to the 
prevalence in bird-feeding mosquitoes.  When infections become more prevalent among birds, infection 
rates may also rise in mosquitoes that feed on both birds and other animals.  Thus, infection within these 
bridge vector mosquitoes seems to enhance the risk of infection to people.  
 
Outbreaks involving two or more human infections associated temporally and spatially may occur with the 
convergence of several factors. One major factor that affects the risk of disease in humans is the 
prevalence of immunity to EEE in the birds that serve as the enzootic reservoir of the virus. EEE infection 
in passerine birds usually results in a mild infection. Following infection, birds become immune to the virus 
and will not harbor it. Following a year of increased viral transmission, the prevalence of EEE immunity in 
birds increases and in subsequent years, the virus may not be able to spread rapidly among these 
reservoir hosts due to the establishment of ‘herd immunity’.  Thus, elevated levels of herd immunity in 
birds may reduce the amplification of EEE in the bird-mosquito-bird cycle, which in turn reduces the 
chance of incidental infections in humans. When herd immunity is low and there are many susceptible 
birds; EEE infections can spread more rapidly and more widely among the birds. 
 
A second major factor affecting the risk of human disease is the abundance of the enzootic vector. 
Certain mosquito species are highly selective as to the kind of host they will seek and feed upon.  
Culiseta melanura (Cs. melanura) mosquitoes feed primarily on birds and are recognized as the 
predominant vector of EEE transmission between passerine birds which are the reservoir of the virus. 
Thus, the intensity of enzootic EEE transmission correlates with the abundance of this enzootic vector. 
Abundant populations of this species provide greater opportunity for the virus to perpetuate or amplify 
within the bird population.  
 
While each factor can individually affect human risk, the greatest risk for human disease occurs in 
seasons when there is both a lower proportion of immunity within the passerine bird populations and the 
mosquito vector population is abundant. The combination of these two factors should permit the greatest 
extent of viral amplification within the environment. This condition may enhance the potential for transfer 
of EEE to humans by a ‘bridge vector’ mosquito, i.e.,  species such as Coquillettidia perturbans, 
Ochlerotatus canadensis, Aedes vexans and Culex species that are less discriminate and will feed on 
birds or humans. 
 
The risk of EEE infection in humans varies by geographical area in Massachusetts, as well as in the 
United States. EEE is more prevalent in areas that support dense populations of passerine birds and 
have favorable breeding conditions for the enzootic vector. In Massachusetts, these areas consist mainly 
of large wetlands containing mature white cedar and red maple swamps that are more common in 
southeastern and northeastern Massachusetts. The majority of EEE cases have occurred in Norfolk, 
Bristol, and Plymouth counties with some cases also occurring in Middlesex County, increasingly in Essex 
County and very rarely in Worcester County or further west. Historically, Cape Cod and the Islands of 
Martha’s Vineyard and Nantucket have not had human cases of EEE. 
] 
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Other major factors that affect the risk of EEE infections for humans are the abundance of specific kinds 
of mosquitoes at critical periods of the transmission season, groundwater levels and the timing of rainfall 
and flooding during the mosquito season.  Participation in outdoor activities increases the risk of exposure 
while the use of personal protective measures (e.g., avoidance of mosquitoes, use of repellent) helps to 
reduce the risk of exposure.  
 
Long-term weather patterns during the fall and winter that produce high ground water levels and snow 
cover may enhance survival of Cs. melanura larval populations. The abundance of these larval 
populations may serve as an early indicator of the potential for human disease later in the year. 
Multiple factors affect the development, survival, and abundance of mosquitoes. It is not currently 
possible to predict either the abundance of mosquitoes or the risks of encountering an infected vector 
later in the season. The best control approach to reduce these vectors must consider multiple factors. 
One approach calls for beginning integrated pest management (IPM) control activities early in the season 
and targeting both the enzootic and human biting vector species. 
 
 
B. West Nile Virus 
 
1. Background                                                                                                                                                                                                       
West Nile virus (WNV) first appeared in the United States in 1999. Since an initial outbreak of infection in 
New York City, the virus has spread across the US from East to West. WNV infection may be 
asymptomatic in some people, but it leads to morbidity and mortality in others.  WNV causes sporadic 
disease of humans, and occasionally results in significant outbreaks. Nationally, close to 1000 human 
cases of WNV neuroinvasive disease (West Nile meningitis and West Nile encephalitis) and WNV fever 
were reported to the CDC in 2010.    
 
The majority of people who are infected with WNV (approximately 80%) will have no symptoms. A 
smaller proportion of people who become infected (~ 20%) will have symptoms such as fever, 
headache, body aches, nausea, vomiting, and sometimes swollen lymph glands.  They may also 
develop a skin rash on the chest, stomach and back. Less than 1% of people infected with WNV will 
develop severe illness, including encephalitis or meningitis.  The symptoms of severe illness can 
include high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, 
muscle weakness, vision loss, numbness and paralysis.  Persons older than 50 years of age have a 
higher risk of developing severe illness. In Massachusetts, there were six fatal WNV human cases 
identified between 2001-2010,  all in individuals eighty years of age or older. 
                                                                                                                                                                                                                        
Following the identification of WNV in birds and mosquitoes in Massachusetts during the summer of 
2000, MDPH arranged meetings between local, state and federal officials, academicians and the public to 
develop recommendations to improve and strengthen key aspects of the state plan for mosquito-borne 
virus surveillance and prevention of mosquito-borne disease. Four workgroups addressed the issues of 
surveillance, risk reduction interventions, pesticide toxicity and communication.   
 
2. Risk Factors for Disease Transmission 
West Nile (WN) virus is amplified by a cycle of continuous transmission between mosquito vectors and 
bird reservoir hosts. Infectious mosquitoes carry virus particles and infect susceptible bird species. WNV 
infection is often fatal in some species of birds, particularly American crows and blue jays (corvids).  
Confirmation of WNV in dead birds historically provided sentinel information used for assessing the risk of 
human WNV infections.  
 
The principal mosquito vectors for West Nile virus on the East Coast are members of the genus Culex. 
These species may be abundant in urban areas, breeding easily in artificial containers such as birdbaths, 
discarded tires, buckets, clogged gutters, catch basins and other standing water sources. Culex pipiens 
and Culex restuans feeds mainly on birds and occasionally on mammals. They will bite humans, typically 
from dusk into the late evening.  
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Cumulative high temperatures and lower precipitation rates are factors that have been associated with 
higher mosquito infection and human illness rates.  Additionally, warmer winter temperature conditions 
may result in larger numbers of Culex species overwintering as adult, with resulting increases in early 
season Culex abundance. 
   
Brackish and freshwater wetlands are the preferred habitat for Culex salinarius which feeds on birds, 
mammals, and amphibians and is well known for biting humans. Ochlerotatus japonicus may be involved 
in the transmission of both WNV and EEE.  
Natural and artificial containers such as tires and rock pools are the preferred larval habitat of this 
mosquito. It feeds mainly on mammals and is a fierce human bite 
 
Activity of the West Nile virus zoonotic cycle varies from year to year.  When a large number of infected 
birds and a high rate of infected mosquitoes occur in a relatively small geographic area, the risk of 
transmission of virus to humans will increase. Surveillance evidence indicates that WNV is established in 
the United States and that virus activity is likely to occur annually. 
 
 A summary of current and historical surveillance information for EEE and WNV in Massachusetts is 
available through www.mass.gov/dph/wnv. 
 
 
 
C. Other viruses 
 
Although other arboviruses are not routinely screened for as part of the MASP, MDPH’s Bureau of 
Laboratory Sciences (i.e, the state public health laboratory) is prepared to rapidly implement screening for 
other relevant viruses carried by mosquitoes that may impact human health. These agents include 
Dengue or Chikungunya viruses, for example. Decisions to implement surveillance for new viruses will be 
based on information pertaining to changes in unusual activity associated with clinical diagnostic testing, 
national reports of new or unusual activity and/or local environmental detection of mosquito vectors that 
support new viral agents as part of an ongoing risk assessment performed by MDPH and CDC’s 
Arbovirus Surveillance Network. 
 
 
 
III. PROGRAM GOALS 
 
Timely and accurate information provided by the MDPH based on surveillance information can be used to 
provide an indication of the level of risk of human disease from WNV and EEE. Based on this surveillance 
information, plans and actions to reduce risk can be developed and implemented when needed.  
 
 Test mosquitoes, horses, humans and other appropriate animals to identify EEE and WNV 
infections. 
 Track trends in incidence and prevalence of EEE and WNV infections by geographic area. 
 Estimate viral infection rates in mosquitoes. 
 Stratify risk in geographic areas as a function of relative risk of human disease.  
 Conduct surveillance for human and animal disease. 
 Educate human and animal medical practitioners on the appropriate procedures for detecting and 
identifying infections and disease caused by mosquito-borne viruses. 
 Recommend measures to reduce virus transmission and disease risk. 
 Educate the public on mosquito-borne diseases and disease risk, and common-sense 
precautions to reduce the risk of infection.  
 Participate in the national Arbovirus Surveillance Network. 
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IV. AGENCY ROLES 
 
A. Massachusetts Department of Public Health (MDPH)  
 
The central purpose of the MASP is to provide information that will guide planning and activities to reduce 
the risk of human disease from EEE and WNV infection. To achieve this, the main objectives are to 
monitor trends in EEE and WNV in Massachusetts; provide timely information on the distribution and 
intensity of WNV and EEE in the environment; perform laboratory diagnosis of WNV and EEE cases in 
humans, horses and other animals; communicate effectively with officials and the public; provide 
guidelines, advice and support on activities that effectively reduce risk of disease; and provide information 
on the safety, anticipated benefits and potential adverse effects of proposed prevention interventions. 
 
MDPH works cooperatively with the SRMCB, regional mosquito control projects and other state agencies 
to collectively identify and support the use of safe and effective mosquito control measures based on 
integrated pest management (IPM) principles. The use of pesticides as a means to reduce human risk is 
one of several methods/strategies to attain this goal.  
 
 
B. State Reclamation and Mosquito Control Board (SRMCB) 
 
The SRMCB oversees mosquito control programs and activities in the Commonwealth of 
Massachusetts. The SRMCB consists of three (3) members representing the Department of Agricultural 
Resources (DAR), Department of Conservation and Recreation (DCR), and Department of Environmental 
Protection (DEP).  Additionally, the SRMCB advises its respective state agency Commissioners on 
actions to reduce mosquito populations based on MDPH findings and characterization of risk.   
 
 
The SRMCB ‘Operational Response Plan to Reduce the Risk of Mosquito-Borne Disease in 
Massachusetts’ addresses the issues related to the operational aspects of adult mosquito surveillance 
and control to prevent and/or reduce the risk of mosquito-borne diseases. The plan may be viewed via 
the web at www.mass.gov/agr/mosquito/arbovirus.htm. 
 
 
In 2006, the SRMCB created a SRMCB Mosquito Advisory Group (MAG). The MAG provides 
independent scientific advice to the SRMCB to assist them in evaluating and assessing data from both 
DPH and mosquito control projects. 
 
 
C. Mosquito Control Projects (MCP) 
 
There are nine (9) organized mosquito control projects or districts located throughout Massachusetts.  All 
of the mosquito control activities of these organized agencies are performed under the aegis of the 
SRMCB.  Mosquito Control Projects collaborate with local boards of health in their jurisdictions to control 
mosquitoes. These locally authorized efforts employ a variety of targeted activities for source reduction, 
larviciding and adulticiding that are in compliance with the SRMCB Operational Response plan.  
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V. SURVEILLANCE  
 
A. Mosquito Surveillance for West Nile Virus (WNV) and Eastern Equine Encephalitis (EEE) Virus 
 
Surveillance of mosquitoes for arboviruses is one of the core functions of the MASP. Monitoring 
mosquitoes for the presence of virus provides a direct estimate of risk to humans. Massachusetts has a 
long-term field surveillance program that was initiated in 1957 for EEE and was modified in 2000 to 
include WNV surveillance. The extensive experience in Massachusetts with surveillance for mosquito-
borne disease provides expertise and capacity to guide risk reduction efforts. The MASP uses a 
comprehensive and flexible strategy that modifies certain surveillance activities in response to trends in 
disease risk.  
 
On an ongoing basis, MASP will continue to monitor national and regional surveillance data and current 
scientific literature to assess risk of newly emerging arboviruses in Massachusetts. In addition, defined 
subsets of mosquito pools will be evaluated by MDPH for the presence of new or emerging viruses 
 
 
1. Fixed and Long-Term Trap Sites   
MASP will collect mosquitoes from areas with activity during the previous year, and from long-term trap 
sites maintained in the EEE high-risk areas of southeastern and eastern Massachusetts (Figure 1). 
Trapping of gravid mosquitoes for testing of WNV is conducted both by mosquito control projects and 
MDPH staff at various locations throughout the state during the arbovirus season. At the William A. 
Hinton State Laboratory Institute (SLI), MDPH’s Bureau of Laboratory Sciences’ tests samples (pools of 
10- 50 specimens) of trapped mosquito collections are tested for WNV and EEE. Test results from routine 
mosquito collections are available within 24 hours. Fixed and long-term trap sites provide the best 
available baseline information for detecting trends in mosquito abundance and virus prevalence and for 
estimating the relative risk of human infection from EEE and WNV. MDPH will monitor larvae from select 
sites in late fall and early spring to determine end-season and pre-season larval abundance. Informal 
monitoring of larval abundance from these sites continues on a weekly basis during the arbovirus season.  
 
2. Supplemental Trap Sites  
When EEE or WNV activity is detected in an area, additional trap sites and/or trap types will be 
used to obtain more information regarding the intensity of virus activity in mosquitoes. The 
following risk indicators may result in the implementation of more intensive mosquito trapping: 1) 
virus isolations in mosquitoes; 2) emergence of large numbers of human-biting mosquitoes in an 
area with a high rate of virus activity and 3) human or equine cases. 
 
3. Mosquito Control Project Trap Sites   
Massachusetts Mosquito Control Projects (MCP’s), are organized under the State Reclamation 
and Mosquito Control Board (SRMCB), housed within the Department of Agricultural Resources. 
The SRMCB is composed of three members; representing the Department of Agricultural 
Resources; the Department of Environmental Protection; and the Department of Conservation 
and Recreation. MCP’s and the SRMCB communicate collaboratively with the MASP. The 
mosquito control projects employ comprehensive integrated pest management (IPM) principles.  
The IPM program uses a variety of available control strategies to impact mosquito abundance. Monitoring 
mosquito abundance is accomplished through various surveillance methods including but not limited to 
larval dip counts and the use of light/ CO2 baited traps and gravid traps. Additional details relating to 
control strategies may be found within the SRMCB Operational Plan. 
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B.  Avian Surveillance: West Nile Virus (WNV) and Eastern Equine Encephalitis Virus (EEE) 
 
MDPH MASP discontinued avian surveillance for WNV as of April, 2009. When it was first introduced into 
the United States, WNV caused high mortality rates in certain species of birds, particularly corvids, thus 
reporting and testing of dead birds was a productive way to detect and monitor WNV activity in an area. 
However, in recent years, the tracking and testing of dead birds has become significantly less useful as 
fewer birds are still susceptible to fatal WNV infections. Monitoring mosquitoes for presence of virus 
remains the primary predictive indicator of human arbovirus disease risk. Therefore, the routine laboratory 
testing of dead wild birds for West Nile virus (WNV) has been completely eliminated. This is consistent 
with recent policy changes in multiple states.  
 
Most birds that are infected with EEE generally survive the viremia, making individual dead bird 
EEE monitoring impractical. Testing of highly suspect bird specimens for EEE infection will be 
done on an as-needed basis as determined by the MDPH State Public Health Veterinarian and 
the MASP.  The MDPH State Pubic Health Veterinarian will determine whether or not it is 
appropriate to test specimens from dead bird clusters for either WNV or EEE infection.   
 
The 24/7 information line (1-866-MassWNV) will be maintained. Callers will receive recorded messages 
that provide information on why birds are no longer tested; information on WNV/EEE disease; and 
instructions for proper disposal of dead birds. More detailed information on this topic is available on the 
MDPH website. 
 
 
C.  Animal Surveillance: West Nile Virus (WNV) and Eastern Equine Encephalitis Virus (EEE)  
 
Specimens from horses and other domestic animals that have severe neurological disease suspected of 
being caused by EEE or WNV infection are tested at SLI. Confirmatory testing, when necessary, may 
take up to nine working days. Massachusetts’ veterinarians, the state Department of Agricultural 
Resources, USDA and Tufts University School of Veterinary Medicine collaborate with the MASP to 
identify and report suspect animal cases. In addition, blood and/or tissue samples from animals from 
other sources, such as zoos or horse stables, or wild animals may be tested. Current information on WNV 
and EEE infections in horses along with clinical specimen submission procedures are disseminated to 
large animal veterinarians, stable owners, and other populations as needed, through mailings and 
postings on the MDPH Arbovirus website at www.mass.gov/dph/wnv. Many horses are immunized 
against infection with WNV and EEE with available veterinary vaccines. Vaccination is the primary means 
of preventing infection in animals.  
 
 
D. Human Surveillance 
 
1. Passive surveillance  
Specimens from human cases of encephalitis and meningoencephalitis are submitted to MDPH and 
screened for human possible causes of infection, including WNV and EEE. Confirmatory testing, when 
necessary, may take three to seven working days. Current information on WNV and EEE infections in 
humans, along with clinical specimen submission procedures are disseminated to physicians (infectious 
disease, emergency medicine and primary care), emergency department directors and hospital infection 
control practitioners through mailings, broadcast faxes, and postings on the MDPH arbovirus website at 
www.mass.gov/dph/wnv. 
 
2. Active surveillance  
If surveillance data indicate a high risk of human disease, active surveillance may be instituted in targeted 
areas. Active surveillance involves regularly contacting local health care facilities to communicate current 
surveillance information, prevention strategies and specimen submission procedures. HHAN (Health and 
Homeland Alert Network) alerts are sent to local boards of health upon confirmation of EEE or WNV in 
any specimen; health care facilities are advised of increased risk status and the corresponding need to 
send specimens to SLI for testing. 
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3. Pesticide related surveillance  
Outreach on pesticide illness reporting will be coordinated by the MDPH Bureau of Environmental Health. 
In the event of an aerial pesticide application, active surveillance efforts will be implemented with 
emergency departments and intensified outreach efforts will be made to health care providers. 
 
 
VI. Communication of Surveillance Information 
 
The MASP will provide information to guide planning and actions to reduce the risk of human disease 
from EEE and WNV.  MDPH works with the SRMCB and MCPs to identify and support the use of risk 
reduction and disease prevention methods that are specific to the causes of disease; and supports 
planning and practices which incorporate the most appropriate prevention methods. Additionally, MDPH 
routinely communicates with health agencies in neighboring states to share relevant Arboviral findings. 
 
Prior to the beginning of the arbovirus season, general disease information and specimen submission 
procedures will be provided to local boards of health via electronic messages from the Massachusetts 
Health and Homeland Alert Network (HHAN). General information and fact sheets are posted on the 
MDPH arbovirus website and available for MCP’s, physicians, veterinarians, animal control officers, and 
other agencies.  
 
Laboratory confirmation of a human WNV or EEE case is immediately reported by telephone to the 
submitting physician, and local board of health (LBOH) in the town where the case resides. If the LBOH 
cannot be reached via telephone in a timely manner, a severe level HHAN alert will be sent.  
 
Laboratory confirmation of infection in a horse (or other veterinary specimen) with WNV or EEE infection 
will be immediately reported by telephone to the submitting veterinarian, the Department of Agricultural 
Resources- Division of Animal Health, Biosecurity and Dairy Services and the LBOH. As with human 
cases, if the LBOH cannot be reached in a timely manner, a severe level HHAN alert will be sent.  
 
Initial positive findings in mosquitoes (WNV and EEE) from a given town will be reported to the LBOH and 
MCP’s by telephone.  Adjacent towns will be notified via a moderate level HHAN alert.  In order to 
encourage risk communication on a focal area level rather than a city/town level, all subsequent positive 
findings in mosquitoes will be reported once daily to all affected towns and adjacent towns, via a 
moderate level HHAN alert. All subsequent positive mosquito findings will be reported once daily to all 
MCP’s and the SRMCB. 
 
 
The MDPH Regional Health Office in the area will offer assistance with local response. All laboratory 
confirmed results for WNV and EEE in humans, horses, other veterinary specimens, mosquitoes are 
provided to the regional health department representative, mosquito control projects and members of the 
SRMCB once the LBOH has been notified. 
 
At the time of notification, MDPH will encourage LBOHs to share the information with other local agencies 
and high-risk populations in their community as appropriate. MDPH provides LBOH with sample press 
releases for their use. Depending on the circumstances, MDPH may also issue a public health alert. In 
addition, weekly summaries of results from mosquito samples submitted and tested will be posted as 
News Items on the HHAN by town.  
 
After all appropriate individuals and agencies have been sent notification, positive surveillance findings 
are made available to the media and general public on the MDPH Arbovirus website at 
www.mass.gov/dph/wnv. This website, which also includes a variety of educational materials related to 
preventing mosquito-borne disease, is updated on a daily basis throughout the arbovirus season. Results 
are also reported to the Centers for Disease Control and Prevention’s (CDC) ArboNET reporting system.  
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MDPH issues public health alerts through the media when surveillance information indicates an 
increased risk of human disease or if a significant surveillance event occurs (for example, the first 
arbovirus activity of the season). In general, alerts will include current surveillance information 
and emphasize prevention strategies.  Alerts will be drafted in consultation with state and local 
agencies.   
 
 
VII. Prevention and Response: Recommendations for Phased Response to Surveillance Data 
 
The guidance provided here is based on current knowledge of risk and appropriateness of 
available interventions to reduce the risk for human disease. Multiple factors contribute to the risk 
of mosquito-transmitted human disease. Decisions on risk reduction measures should be made 
after consideration of all surveillance information for that area at that time.  
 
Public awareness of what can be done to reduce risk of infection is of utmost importance. The level of 
EEE and WNV activity may occasionally present a potential for increased virus transmission to humans. 
Typically, risk for any individual is expected to be relatively low, and the routine precautions taken by 
individuals may be sufficient to reduce opportunities for infection. These guidelines take into consideration 
the complexity of reducing risk of human disease from EEE and WNV infection and form a framework for 
decision-making.  
 
General guidelines are provided for an array of situations that are noted in the Surveillance and 
Response Plan tables that follow. Specific situations must be evaluated individually and options 
discussed before final decisions on specific actions are made. The assessment of risk from mosquito-
borne disease is complex and many factors modify specific risk factors. MDPH assesses risk and works 
with local public health agencies, mosquito control projects, and the SRMCB to develop the most 
appropriate response activities to reduce the risk of human disease. There is no single indicator that can 
provide a precise measure of risk, and no single action that can assure prevention of infection. 
 
When recommending the use of mosquito larvicides or adulticide, MDPH works collaboratively with other 
state agencies, the SRMCB and regional mosquito control projects to collectively identify and support the 
use of safe and effective mosquito control measures based on integrated pest management (IPM) 
principles.  
 
 
A. MDPH Guidance  
 
The MDPH Arbovirus Program will determine human risk levels as outlined in the phased response tables 
of this plan. Risk levels are defined for focal areas. “Focal Areas” may incorporate multiple communities, 
towns or cities. Factors considered in the determination of human risk in a focal area include: mosquito 
habitat, prior virus isolations, human population densities, timing of recent isolations of virus in 
mosquitoes, the cyclical nature of human outbreaks (EEE), current and predicted weather and seasonal 
conditions needed to present risk of human disease.  
 
If the risk of an outbreak becomes widespread and involves multiple jurisdictions, MDPH will confer with 
local health agencies, SRMCB, MCP’s, and MAG to discuss the use of intensive mosquito control 
methods and determine whether measures need to be taken by the agencies to allow for and assure that 
the most appropriate mosquito control interventions are applied to reduce risk of human infection. These 
interventions may include state-funded aerial application of mosquito adulticide. Factors to be considered 
in making this decision include the cyclical, seasonal and biological conditions needed to present an 
ongoing high risk of WNV or EEE human disease.  
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Once significant human risk has been identified in a focal area by MDPH, MDPH will coordinate with the 
SRMCB to determine the adulticide activities that should be considered and implemented in response.  
The SRMCB will provide recommendations on appropriate pesticide(s), route and means of treatment for 
the specific treatment areas. Based on historical experience with EEE, MDPH has identified specific 
critical indicators for EEE, infection rates, and provides specific risk reduction and prevention guidance for 
seasons with an anticipated increased EEE risk. 
 
 
B. Risk Reduction and Prevention Guidance for Seasons with Indicators of Increased EEE Risk 
 
Activities that may be undertaken in response to indicators of increased risk include: 
 
 MDPH may release public health alerts throughout the season to remind the public of the steps to 
take to reduce their risk of exposure to mosquitoes. 
 MCP’s may increase their source reduction activities to reduce mosquito-breeding habitats and to 
reduce adult mosquito abundance. This may include ground and aerial larviciding. 
 After sustained findings of positive mosquito isolates, if not already in progress, adult mosquito 
control efforts including targeted ground adulticiding operations should be considered. The decision to 
use ground-based adult mosquito control will depend on critical modifying variables including the time 
of year, mosquito population abundance and proximity of virus activity to at-risk populations.  
 Other intensified efforts may be implemented following coordination between MDPH and other 
agencies including DEP, MDAR, and DCR. 
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Aerial Adulticide Application in Response to Mosquito-Borne Disease Threat 
2011 Multi-Agency Response Flowchart 
 
 
1. Determination of Response  
 When human risk is elevated to a high level of concern as indicated by the MDPH Surveillance 
and Response Plan; DPH/BID will determine, in consultation with Mosquito Control Projects, 
SRMCB and the Mosquito Advisory Group whether aerial application is warranted.  
 
 
2. Characterization of Area of Risk 
 Once consensus is obtained, DPH/BID characterizes the area of risk and delineates the perimeter 
of the spray area based on mosquito and virus surveillance. 
 DPH/BID provides the GIS perimeter map to inter-agency collaborators as soon as possible. 
 
 
3. Commissioner Certification 
 DPH BID requests Commissioner of Public Health issue a “Certification that Pesticide 
Application is Necessary to Protect Public Health”  
 
 
 
Action Items 4a-4c Occur Simultaneously: 
 
4a. Determination of Appropriate Pesticide 
 Prior to July 1 of each season, DPH/BEH and DAR will determine the type of pesticide to be 
used in the event that an aerial application will be warranted and obtain any EPA pesticide 
waivers, if necessary, for use in aerial application.  
 In the event that aerial application is warranted, DPH/BEH and DAR will confirm this selected 
pesticide for use. 
 
 
4b.Determination of No-Spray Zones 
 No- aerial spray zones (mosquito treatment sensitive areas data layers) defined: 
1)Certified organic farms 
2)Priority habitats for spray sensitive state-listed rare species  
3)Surface water supply resource areas 
4)Commercial fish hatcheries/aquaculture 
 DAR reviews any emergency waivers needed to use pesticides on school property and ensure 
compliance with pesticide laws.  
 DAR/SRMCB will submit a ‘Notice of Intent’ to EPA to obtain an NPDES permit within 30 
days of the aerial adulticide event. 
 
 
4c.Exclusion/Inclusion of Priority Habitats: 
 DPH/BID will determine, in consultation with  SRMCB, DAR, DEP, and DFW  if spraying in 
mosquito treatment sensitive areas is necessary to protect the public health.  
 If spraying in these areas is necessary to reduce the risk to public health then: 
o DPH BID requests a permit from DFW be issued to DAR for taking endangered, 
threatened, or special concern species. 
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5. Preparation of Final GIS Data Map  
 DAR coordinates compilation of mosquito treatment sensitive areas data layers (no-spray zones) 
developed by DAR, DFW, and DEP within designated DPH spray area into a final map. 
 
 
 
6. Environmental Monitoring 
 DEP, DAR, and DPH/BEH notify partner environmental agency collaborators of planned 
environmental monitoring to provide opportunity for input/collaboration.  
     DEP, DAR, and DPH/(BEH/SLI) initiate plans for pre/post-monitoring for public drinking water 
reservoirs, honey bees, macro-invertebrates, and cranberries in designated spray area. 
 
7. Emergency Room and Poison Control Contacts 
 DPH/BEH contacts and provides pesticide illness surveillance protocols to emergency 
departments, poison control centers, and local health departments. 
 
 
 
8. Notification of Date & Time of Application 
 DAR and DPH provide public notices regarding the locations, dates, and times of aerial spraying. 
 DAR will maintain a website with GIS maps of the aerial spray area and will update this site 
daily during spray operations. 
 DPH will provide recorded hotline information regarding the spray zone, precautionary 
measures, and telephone numbers to report fish kills or other environmental impacts. 
 
 
 
9. Operational Procedures-Aerial Application 
 DAR/SRMCB initiates aerial spray operations using collective guidance and consensus 
developed through multi-agency, cross secretariat process.  
 The aerial application operational procedures are followed as described in the SRMCB 
Operational Response Plan. 
 
 
 
 
DPH- Department of Public Health 
BID- Bureau of Infectious Diseases 
BEH- Bureau of Environmental Health 
BLS- Bureau of Laboratory Sciences  
 
DAR- Department of Agricultural Resources 
SRMCB- State Reclamation and Mosquito Control Board 
DFG-Department of Fish and Game 
DFW- Division of Fisheries and Wildlife  
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Table 1.  Guidelines for Phased Response to WNV Surveillance Data  
 
Risk 
Category 
Probability of 
human outbreak 
Definition of Risk Category for a Focal Area
1
 
 
Recommended Response  
1 Remote All of the following conditions must be met: 
 
Prior Year 
No prior year WNV activity detected in the focal 
area. 
And 
 
Current Year 
No current surveillance findings indicating WNV 
activity in mosquitoes in the focal area                   
 
       And 
 
No animal or human cases. 
 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, but 
not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public on 
personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3. MDPH provides recorded information on WNV/EEE 
disease, and disposal of dead birds via MDPH WNV 
information line (1-866-MASS-WNV). 
 
4. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
5. Routine collection and testing of mosquitoes. 
 
6. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey. In making a 
decision to use larvicide consider the abundance of 
Culex larvae, intensity of prior virus activity and 
weather. 
 
7.  Locally established, standard, adult mosquito 
control activities are implemented.  No specific 
supplemental control efforts are recommended. 
 
 
8. Passive human and horse surveillance. 
 
9.  Emphasize the need for schools to comply with MA 
requirements for filing outdoor IPM plans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1
 Focal Area- May incorporate multiple communities, towns or cities. Factors considered in determination of  
human risk in a focal area include mosquito habitat, prior isolations, human population densities, timing of current 
isolations of virus in mosquitoes, the cyclical and seasonal conditions needed to present risk of human disease  
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2 Low Prior Year 
Any WNV activity in mosquitoes in the 
community or focal area 
 
Or 
 
Current Year 
 
1. Sporadic WNV activity in mosquitoes in the 
focal area.  
And 
 
2. No animal or human cases  
 
Definitions: 
Sporadic WNV activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained WNV activity- when mosquito isolates 
are detected for 2 or more consecutive weeks 
within one focal area.  
 
 
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2.  Increase larval control and source reduction 
measures. 
 
3. Public health alert sent out by MDPH in response to 
first WNV virus positive mosquito pool detected during 
the season.  The alert will summarize current 
surveillance information and emphasize personal 
prevention strategies. 
 
4. Locally established standard adult mosquito control 
activities continue. 
 
 
3 Moderate Prior Year       
Confirmation of one or more human or animal 
WNV cases; or sustained WNV activity in 
mosquitoes for 2 or more weeks. 
 
Or 
 
Current year          
 
                                      
1. Sustained WNV activity plus at least one 
multiple meteorological or ecological conditions 
(such as above average temperatures, dry 
conditions, or larval abundance) associated with 
increased abundance and increased risk of 
human disease.    
 
 
Or 
 
2. A single WNV isolate from mosquitoes likely to 
bite humans such as Oc.japonicus or Oc. 
Canadensis.  
 
 
And 
 
3. No animal or human WNV cases                                                                 
 
Response as in category 2, plus: 
 
1.  Outreach and public health educational efforts are 
intensified including media alerts as needed. 
 
 2. If not already in progress, standard, locally 
established adult mosquito control efforts including 
targeted ground adulticiding operations should be 
considered against Culex mosquitoes and other 
potential vectors, as appropriate.   The decision to use 
ground-based adult mosquito control will depend on 
critical modifying variables including the time of year, 
mosquito population abundance and proximity of virus 
activity to at-risk populations.  
 
3. Duly authorized local officials may request that DPH 
Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-spray 
requests. 
 
4. Supplemental mosquito trapping and testing may be 
performed in areas with positive WNV findings.  
  
5.  Local boards of health are contacted via phone or 
HHAN (Health and Homeland Alert Network) upon 
confirmation of WNV in any specimen. Advise health 
care facilities of increased risk status and 
corresponding needs to send specimens to SLI for 
testing. 
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4 High Current Year 
 
1. Sustained or increasing WNV activity in 
mosquitoes plus multiple meteorological or 
ecological conditions (such as above average 
temperatures, dry conditions, increased larval 
abundance) associated with elevated mosquito 
abundance; and increasing minimum infection 
rates.    
 
    
 
                 And/or 
 
2.  MDPH confirmation of WNV in an animal at 
any time 
 
                  And/ or, 
 
3.  MDPH confirmation of WNV in a human at 
any time 
 Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public health 
alerts from MDPH, press releases from local boards of 
health, local newspaper articles, cable channel 
interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities (nursing 
homes, schools, etc.) and educate them on personal 
protection  
 d.  Advisory information on pesticides provided by 
MDPH Bureau of Environmental Health.                                                                    
e. Urge towns and schools to consider rescheduling 
outdoor events. 
 
2. Intensify and expand active surveillance for human 
cases. 
   
3. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control. Town or city may request preemption 
of homeowner private property no-spray requests. 
 
4. Local officials should evaluate all quantitative 
indicators including population density and time of year 
and may proceed with focal area aerial adulticiding. 
 
5.  Duly authorized local officials may request that the 
DPH Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-spray 
requests. 
 
6. MDPH will confer with local health officials, SRMCB 
and Mosquito Control Projects to determine if the risk 
of disease transmission threatens to cause multiple 
human cases and warrants classification as level 5. 
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5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Critical  Current Year 
 
1. More than 1 confirmed human case in a 
community or focal area 
 
Or 
 
2 .More than 1 confirmed animal case in a 
community or focal area 
  
Or  
 
3. Multiple quantitative measures indicating 
critical risk of human infection (e.g. early season 
positive surveillance indicators, and sustained  
elevated field mosquito infection rates, and horse 
or mammal cases indicating escalating epizootic 
activity)   
 
 
 
Response as in category 4, plus: 
1.  Continued highly intensified public outreach 
messages on personal protective measures. Frequent 
media updates and intensified community level 
education an outreach efforts. 
2. The MDPH Arbovirus Program will determine human 
risk levels as outlined in this plan. If risk of outbreak is 
widespread and covers multiple jurisdictions, MDPH 
will confer with local health agencies, SRMCB and 
Mosquito Control Projects to discuss the use of 
intensive mosquito control methods and determine if 
measures need to be taken by the agencies to allow for 
and assure that the most appropriate mosquito control 
interventions are applied to reduce risk of human 
infection. These interventions may include state-funded 
aerial application of mosquito adulticide. 
Factors to be considered in making this decision 
include the cyclical, seasonal and biological conditions 
needed to present a continuing high risk of WNV 
human disease.  
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk by 
making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C.  Targeted treatment areas  
 
3. MDPH Bureau of Environmental Health  will initiate 
active surveillance via emergency departments and 
with health care provides only if aerial spraying 
commences. 
 
4. MDPH will designate high-risk areas where it has 
issued a certification that pesticide application is 
necessary to protect public health in order to preempt 
homeowner private property no-spray requests. 
If this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in areas 
of intensive virus activity. 
 
6. MDPH will communicate with health care providers 
in the affected area regarding surveillance findings and 
encourage prompt sample submission from all clinically 
suspect cases. 
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Table 2.  Guidelines for Phased Response to EEE Surveillance Data 
 
Risk 
Category 
Probability of 
human outbreak 
Definition of Risk Category for a Focal Area
2
 
 Recommended Response 
1 Remote All of the following conditions must be met: 
Prior Year 
No EEE activity detected in a community or focal 
area 
 
And 
Current Year 
 No current surveillance findings indicating EEE 
activity in mosquitoes in the focal area                   
 
                  
And 
No animal or human EEE cases. 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, 
but not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public 
on personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3.  Routine collection and testing of mosquitoes. 
 
4. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
 
5. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey and targeted 
at the likely amplifying bridge vector species. In 
making a decision to use larvicide consider the 
prevalence of Culiseta and bridge vector larvae, 
intensity of prior virus activity, and weather.        
 
6.  Locally established, standard, adult mosquito 
control activities are implemented.  No specific 
supplemental control efforts are recommended. 
 
 
7. Passive human and horse surveillance. 
 
8.  Emphasize the need for schools to comply with 
MA requirements for filing outdoor IPM plans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                          
                                                 
2 Focal Area- May incorporate multiple communities, towns or cities.  Factors considered in the determination of 
human risk in a focal area include: mosquito habitat, prior isolations, human population densities, timing of current 
isolations of virus in mosquitoes, and the cyclical nature of human EEE outbreaks, current weather and seasonal 
conditions needed to present risk of human disease.  
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2 Low Prior Year 
EEE activity in mosquitoes in the prior year in 
the focal area 
 
Or 
 
Current Year 
1. Sporadic EEE isolations in  Cs. melanura 
mosquito in the community or focal area after 
July 1   
 
And 
 
2. No animal or human cases. 
 
 
Definitions: 
Sporadic EEE activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained EEE activity- when mosquito isolates 
are detected for 2 or more consecutive weeks 
within one focal area.  
 
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2.  Increase larval control and source reduction 
measures. 
 
3. Locally established standard adult mosquito 
control activities continue 
 
4. Public health alert sent out by MDPH in response 
to first EEE mosquito isolate detected during the 
season.  The alert will summarize current 
surveillance information and emphasize personal 
prevention strategies. 
   
 
 
3 Moderate Prior Year                                                                                                                           
Confirmation of one human EEE case in the 
community or focal area; or 1 or more EEE 
horse, mammal or ratite case(s); or sustained 
EEE activity in mosquitoes.   
 
Or 
  
Current year                                                                                             
1. No animal or human EEE cases in current 
year 
 
And 
 
2. Sustained EEEV activity in Cs. melanura after 
July 1 with minimum infection rates that are at or 
below mean levels for focal area trap sites.  
                      
 Or 
 
3. Sustained EEEV activity plus at least one 
multiple meteorological or ecological condition 
(rainfall, temperature, seasonal conditions, or 
larval abundance) associated with elevated 
mosquito abundance and thus likely to increase 
the risk of human disease 
 
Or 
4. A single EEEV isolate from mosquitoes likely 
to bite humans (bridge vector species) 
                
Or 
5. A single EEEV isolate in mosquitoes of any 
species, prior to   July 1. 
Response as in category 2, plus:
 
1.  Outreach and public health educational efforts 
are intensified including media alerts as needed. 
 
 2. If not already in progress, standard, locally 
established adult mosquito control efforts including 
targeted ground adulticiding operations should be 
considered. The decision to use ground-based adult 
mosquito control will depend on critical modifying 
variables including the time of year, mosquito 
population abundance and proximity of virus activity 
to at-risk populations.  
 
3. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
4. Supplemental mosquito trapping and testing in 
areas with positive EEEV findings.  Notify all boards 
of health of positive findings.   
 
5. Public health alert sent out by MDPH in response 
to first pool of EEE positive mammal-biting 
mosquitoes detected during the season.  The alert 
will summarize current surveillance information and 
emphasize personal prevention strategies. 
6.  HHAN (Health and Homeland Alert Network) 
alerts or phone calls are provided to local boards of 
health upon confirmation of EEE in any specimen; 
advise health care facilities of increased risk status 
and corresponding needs to send specimens to SLI 
for testing. 
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4 High Current Year 
 
 
1, Sustained or increasing EEEV activity in Cs. 
melanura with weekly mosquito minimum 
infection rates above the mean. 
             
 Or 
 
2. Sustained or increasing EEE activity in 
mosquitoes plus multiple meteorological or 
ecological conditions (rainfall, temperature, 
seasonal conditions, or larval abundance) 
associated with elevated mosquito abundance 
and thus very likely to increase the risk of human 
disease.     
 
And/or 
 
3..Isolation of EEEV in more than 1 pool of 
bridge vector mosquitoes 
 
And/or 
 
4. Confirmation of EEE in an animal at any time 
 
And/or 
 
5. Confirmation of EEE in a human at any time 
 
Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public 
health alerts from MDPH, press releases from local 
boards of health, local newspaper articles, cable 
channel interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities 
(nursing homes, schools, workers employed in 
outdoor occupations, etc.) and educate them on 
personal protection  
 d.  Advisory information on pesticides provided by 
MDPH Bureau of Environmental Health.                                                                    
e. Urge towns and schools to consider rescheduling 
outdoor events. 
   
2. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control. Town or city may request 
preemption of homeowner private property no-spray 
requests. 
 
3.  Active surveillance for human cases is intensified. 
Health care facilities are advised of increased risk 
status and corresponding needs to send specimens 
to SLI for testing. 
4. Local officials should evaluate all quantitative 
indicators including population density and time of 
year and may proceed with focal area aerial 
adulticiding. 
 
5. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
6. MDPH will confer with local health officials, 
SRMCB and Mosquito Control Projects to determine 
if the risk of disease transmission threatens to cause 
multiple human cases and warrants classification as 
level 5. 
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5 Critical Current Year 
 
1. More than 1 confirmed human EEE case  
 
Or 
 
2. Multiple EEE animal cases 
 
Or 
 
3. Multiple quantitative measures indicating 
critical risk of human infection (e.g. early season 
positive surveillance indicators, and sustained  
high mosquito infection rates, and horse or 
mammal case indicating escalating epizootic 
activity)   
 
 
 
  
Response as in category 4, plus: 
1.  Continued highly intensified public outreach 
messages on personal protective measures. 
Frequent media updates and intensified community 
level education an outreach efforts. 
 
2. The MDPH Arbovirus Program will determine 
human risk levels as outlined in this plan. If risk of 
outbreak is widespread and covers multiple 
jurisdictions, MDPH will confer with local health 
agencies, SRMCB and Mosquito Control Projects to 
discuss the use of intensive mosquito control 
methods and determine the measures needed to be 
taken by the agencies to allow for and assure that 
the most appropriate mosquito control interventions 
are applied to reduce risk of human infection. These 
interventions may include state-funded aerial 
application of mosquito adulticide. 
 
Factors to be considered in making this decision 
include the cyclical, seasonal and biological 
conditions needed to present a continuing high risk 
of EEE human disease.  
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk 
by making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C.  Targeted treatment areas  
  
  
3. Bureau of Environmental Health will initiate active 
surveillance via emergency departments and with 
health care provides only if aerial spraying 
commences. 
 
4.  MDPH will designate high-risk areas where 
individual no spray requests may be preempted by 
local and state officials based on this risk level.  If 
this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in 
areas of intensive virus activity. 
 
6. MDPH will communicate with health care 
providers in the affected area regarding surveillance 
findings and encourage prompt sample submission 
from all clinically suspect cases. 
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Appendix 1:  Mosquitoes Associated with Arboviral Activity in Massachusetts 
 
Aedes vexans – Is a common nuisance mosquito. Temporary flooded areas such as woodland pools and 
natural depressions are the preferred larval habitat of this mosquito. It feeds on mammals and is a fierce 
human biter. This species is typically collected from May to October. Ae vexans is an epizootic vector of 
eastern equine encephalitis (EEE) Virus. 
 
Coquillettidia perturbans - Cattail marshes are the primary larval habitat of this mosquito. It feeds on 
both birds and mammals. It is a persistent human biter and one of the most common mosquitoes in 
Massachusetts. This species is typically collected from June to September. Cq perturbans is an epizootic 
vector of EEE. 
 
Culex pipiens – Artificial containers are the preferred larval habitat of this mosquito. It feeds mainly on 
birds and occasionally on mammals. It will bite humans, typically from dusk into the evening. This species 
is regularly collected from May to October but can be found year round as it readily overwinters in man-
made structures. Cx pipiens has been implicated as a vector of West Nile Virus (WNV). 
 
Culex restuans – Natural and artificial containers are the preferred larval habitat of this mosquito. It 
feeds almost primarily on birds but has been known to bite humans on occasion. This species is typically 
collected from May to October but can be found year round as it readily overwinters in man-made 
structures.  Cx restuans has been implicated as a vector of WNV.   
 
Culex salinarius – Brackish and freshwater wetlands are the preferred habitat of this mosquito. It feeds 
on birds, mammals, and amphibians and is well known for biting humans. This species is typically 
collected from May to October but can be found year round as it readily overwinters in natural and man-
made structures. Cx salinarius may be involved in the transmission of both WNV and EEE.   
 
Culiseta melanura –White cedar and red maple swamps are the preferred larval habitat of this mosquito. 
It feeds almost exclusively on birds. This species is typically collected from May to October. Cs melanura 
is the primary enzootic vector of EEE.  
 
Ochlerotatus canadensis – Shaded woodland pools are the preferred larval habitat of this mosquito. It 
feeds mainly on birds and mammals but is also known to take blood meals from amphibians and reptiles. 
This mosquito can be a fierce human biter near its  larval habitat. This species is typically collected from 
May to October. Oc canadensis is an epizootic vector of EEE. 
 
Ochlerotatus japonicus – Natural and artificial containers such as tires, catch basins, and rock pools are 
the preferred larval habitat of this mosquito. It feeds mainly on mammals and is a fierce human biter. This 
species is typically collected from May to October. Oc japonicus may be involved in the transmission of 
both WNV and EEE. 
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Figure 1:  Location of MDPH EEE Mosquito Trap Sites 
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